News

FDA to undo some layoffs, after cuts to inspections and drug safety
Multiple current and laid-off FDA employees said the abrupt layoffs had resulted in delays and disruptions to the agency's ...
FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
The FDA’s ‘Bullish Signal’ to Biotech Could Backfire
The notion that we can simultaneously demand expedited approvals while gutting the agency is misguided.
Not so fast on the FDA’s food dye ban — the Supreme Court has changed the rules
The Supreme Court’s recent reversal of the Chevron doctrine means every new regulation is now living on borrowed time — and ...
FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
Make America Healthy Again: FDA rolls out new plan to ban synthetic food dye
The Big Weekend Show' co-hosts guess dye-free foods and weigh in on Health and Human Services Secretary Robert F. Kennedy Jr.
FDA suspends dairy quality testing amid federal workforce cuts. Is it safe to consume milk?
The testing of Grade A dairy products like pasteurized and raw milk, cheese, and yogurt are currently being paused by the FDA ...
FDA head falsely claims no scientists laid off, as agency shutters food safety labs
The head of the Food and Drug Administration has repeatedly claimed in recent interviews that no scientists have been laid ...
The FDA suspend quality control testing program for dairy. How will it impact Louisiana?
After staff and funding cuts across the HHS, the FDA has suspended its quality control program for testing dairy products.
Novavax says its COVID-19 shot is on track for full FDA approval after delay
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
FDA chief says no current plans to restrict mifepristone access
Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...
FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...